Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)

BIOLOGICAL4 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Influenza

Phase 1

H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults

CompletedNCT00294099

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2006-03-31End: 2007-03-31Updated: 2013-06-03

St. Jude Open Label H5 Trial

CompletedNCT00311675

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2006-04-30End: 2006-12-31Updated: 2010-08-27

Open-Label Study of H5 Vaccine in Participants of Protocol 04-077

CompletedNCT00402649

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2007-02-28End: 2007-12-31Updated: 2011-06-13

Phase 2

H5 Booster After a Two Dose Schedule

CompletedNCT00240968

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2005-10-31End: 2006-07-31Updated: 2013-08-16

Related Papers

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans.

2008-02-0147 citations